Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016 (2016), Article ID 8915809, 12 pages
http://dx.doi.org/10.1155/2016/8915809
Research Article

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia

1Genomics Research Center, Academia Sinica, Taipei 115, Taiwan
2Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 112, Taiwan
3Department of Urology, National Chen Kung University Hospital, College of Medicine, National Chen Kung University, Tainan 701, Taiwan
4Chemistry Department, National Taiwan University, Taipei 106, Taiwan
5Institute of Atomic & Molecular Sciences, Academia Sinica, Taipei 106, Taiwan

Received 23 October 2015; Revised 22 January 2016; Accepted 3 February 2016

Academic Editor: Alex J. Rai

Copyright © 2016 Chun-Jen Hsiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zhang, X.-J. Li, D. B. Martin, and R. Aebersold, “Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry,” Nature Biotechnology, vol. 21, no. 6, pp. 660–666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. F. Gittes, “Prostate-specific antigen,” The New England Journal of Medicine, vol. 317, no. 15, pp. 954–955, 1987. View at Publisher · View at Google Scholar · View at Scopus
  3. T. A. Stamey, N. Yang, A. R. Hay, J. E. McNeal, F. S. Freiha, and E. Redwine, “Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate,” The New England Journal of Medicine, vol. 317, no. 15, pp. 909–916, 1987. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. D. Wolf, R. C. Wender, R. B. Etzioni et al., “American Cancer Society guideline for the early detection of prostate cancer: update 2010,” CA: A Cancer Journal for Clinicians, vol. 60, no. 2, pp. 70–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. J. Wilt, P. T. Scardino, S. V. Carlsson, and E. Basch, “Prostate-specific antigen screening in prostate cancer: perspectives on the evidence,” Journal of the National Cancer Institute, vol. 106, no. 3, Article ID dju010, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Y. White, L. Rodemich, J. O. Nyalwidhe et al., “Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids,” Journal of Proteome Research, vol. 8, no. 2, pp. 620–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Tajiri, C. Ohyama, and Y. Wada, “Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach,” Glycobiology, vol. 18, no. 1, pp. 2–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Li, Y. Tian, T. Rezai et al., “Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues,” Analytical Chemistry, vol. 83, no. 1, pp. 240–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Leymarie, P. J. Griffin, K. Jonscher et al., “Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012,” Molecular and Cellular Proteomics, vol. 12, no. 10, pp. 2935–2951, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Song, A. Mayampurath, C.-Y. Yu, H. Tang, and Y. Mechref, “Glycoproteomics: identifying the glycosylation of prostate specific antigen at normal and high isoelectric points by LC-MS/MS,” Journal of Proteome Research, vol. 13, no. 12, pp. 5570–5580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Sanda, P. Pompach, Z. Brnakova, J. Wu, K. Makambi, and R. Goldman, “Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease,” Molecular and Cellular Proteomics, vol. 12, no. 5, pp. 1294–1305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Hong, C. B. Lebrilla, S. Miyamoto, and L. R. Ruhaak, “Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring,” Analytical Chemistry, vol. 85, no. 18, pp. 8585–8593, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-J. Lee, H.-J. Cha, J.-S. Lim et al., “Abundance-ratio-based semiquantitative analysis of site-specific N-linked glycopeptides present in the plasma of hepatocellular carcinoma patients,” Journal of Proteome Research, vol. 13, no. 5, pp. 2328–2338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. D. Sherrod, M. V. Myers, M. Li et al., “Label-free quantitation of protein modifications by pseudo selected reaction monitoring with internal reference peptides,” Journal of Proteome Research, vol. 11, no. 6, pp. 3467–3479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Schilling, M. J. Rardin, B. X. MacLean et al., “Platform-independent and label-free quantitation of proteomic data using MS1 extracted ion chromatograms in skyline: application to protein acetylation and phosphorylation,” Molecular and Cellular Proteomics, vol. 11, no. 5, pp. 202–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Ohyama, M. Hosono, K. Nitta et al., “Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy,” Glycobiology, vol. 14, no. 8, pp. 671–679, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. V. Dwek, A. Jenks, and A. J. C. Leathem, “A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia,” Clinica Chimica Acta, vol. 411, no. 23-24, pp. 1935–1939, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Kosanović and M. M. Janković, “Sialylation and fucosylation of cancer-associated prostate specific antigen,” Journal of B.U.ON., vol. 10, no. 2, pp. 247–250, 2005. View at Google Scholar · View at Scopus
  19. M. M. Janković and M. M. Kosanović, “Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns,” Clinical Biochemistry, vol. 38, no. 1, pp. 58–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Tabarés, C. M. Radcliffe, S. Barrabés et al., “Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA,” Glycobiology, vol. 16, no. 2, pp. 132–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Peracaula, G. Tabarés, L. Royle et al., “Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins,” Glycobiology, vol. 13, no. 6, pp. 457–470, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Bolduc, L. Lacombe, A. Naud, M. Grégoire, Y. Fradet, and R. R. Tremblay, “Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/ml and 10 ng/ml,” Canadian Urological Association Journal, vol. 1, no. 4, pp. 377–381, 2007. View at Google Scholar · View at Scopus
  23. C. Stephan, K. Jung, E. P. Diamandis, H. G. Rittenhouse, M. Lein, and S. A. Loening, “Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer,” Urology, vol. 59, no. 1, pp. 2–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Pannek, H. G. Rittenhouse, C. L. Evans et al., “Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer,” Urology, vol. 50, no. 5, pp. 715–721, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Morelle and J.-C. Michalski, “Analysis of protein glycosylation by mass spectrometry,” Nature Protocols, vol. 2, no. 7, pp. 1585–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. M. Segu and Y. Mechref, “Characterizing protein glycosylation sites through higher-energy C-trap dissociation,” Rapid Communications in Mass Spectrometry, vol. 24, no. 9, pp. 1217–1225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Hart-Smith and M. J. Raftery, “Detection and characterization of low abundance glycopeptides via higher-energy C-trap dissociation and orbitrap mass analysis,” Journal of the American Society for Mass Spectrometry, vol. 23, no. 1, pp. 124–140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Stavenhagen, H. Hinneburg, M. Thaysen-Andersen et al., “Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides,” Journal of Mass Spectrometry, vol. 48, no. 6, pp. 627–639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. H. N. Behnken, A. Ruthenbeck, J.-M. Schulz, and B. Meyer, “Glycan analysis of Prostate Specific Antigen (PSA) directly from the intact glycoprotein by HR-ESI/TOF-MS,” Journal of Proteome Research, vol. 13, no. 2, pp. 997–1001, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Iwakiri, K. Grandbois, N. Wehner, H. C. B. Graves, and T. Stamey, “An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands,” The Journal of Urology, vol. 149, no. 4, pp. 783–786, 1993. View at Google Scholar · View at Scopus
  31. H. S. Saǧlam, O. Köse, F. Özdemir, and Ö. Adsan, “Do the values of prostate specific antigen obtained from fresh and dried urine reflect the serum measurements?” Urology Annals, vol. 5, no. 2, pp. 99–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. F. H. Schröder, J. Hugosson, M. J. Roobol et al., “Screening and prostate-cancer mortality in a randomized European study,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1320–1328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. F. Shariat, P. T. Scardino, and H. Lilja, “Screening for prostate cancer: an update,” The Canadian Journal of Urology, vol. 15, no. 6, pp. 4363–4374, 2008. View at Google Scholar · View at Scopus
  34. R. L. Grubb III, P. F. Pinsky, R. T. Greenlee et al., “Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial,” BJU International, vol. 102, no. 11, pp. 1524–1530, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Oesterling, “Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate,” The Journal of Urology, vol. 145, no. 5, pp. 907–923, 1991. View at Google Scholar · View at Scopus
  36. G. L. Andriole Jr., “Screening for prostate cancer,” British Medical Journal, vol. 341, Article ID c4538, 2010. View at Publisher · View at Google Scholar · View at Scopus